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ABSTRACT 
Background and Objectives: Undiagnosed diabetes mellitus (DM) or impaired glucose tolerance (IGT) is not 
uncommon in patients with coronary atherosclerosis and is known to be associated with abnormal scores for 
atherosclerosis surrogates. We sought to determine the prevalence of undiagnosed DM or IGT, and the association 
between insulin resistance (IR) and atherosclerosis surrogates in patients with coronary atherosclerosis. Subjects 
and Methods: The study population consisted of 187 consecutive patients with angiographically proven coronary 
atherosclerosis (mean: 61 years old, 94 males). We measured carotid intima-media thickness (IMT) and flow me-
diated brachial artery dilatation (FMD). We also did oral glucose tolerance tests (OGTT), quantitative insulin-
sensitivity check indexes (QUICKI) and homeostasis model assessment-IR  (HOMA-IR).  Results: Abnormal 
OGTT was found in 164 patients (87.7%), even though there were only 63 known cases of DM (33.7%). There 
were 58 patients (31%) with newly diagnosed IGT and 43 patients (23%) with newly diagnosed DM. There were 
71 patients (38%) who had IR (defined as measured HOMA-R ≥3.0). HOMA-IR showed a positive correlation 
with body mass index (BMI) (r=0.275, p<0.001) and triglycerides (r=0.2, p=0.01), whereas QUICKI had a 
negative correlation with BMI (r=-0.26, p<0.001), total cholesterol (r=-0.15, p=0.04), triglycerides (r=-0.21, 
p=0.004) and low-density lipoprotein-cholesterol (LDL-C) (r=-0.17, p=0.02). HOMA-IR and QUICKI were 
not significantly correlated with IMT or FMD. Conclusion: This study suggests that there is a high incidence of 
undiagnosed DM and IGT, but atherosclerosis surrogates are not associated with IR in patients with coronary 
atherosclerosis. (Korean Circ J 2010;40:62-67) 
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Introduction 
 
The worldwide prevalence of diabetes mellitus (DM) 
has been reported to be higher than 170,000,000 patients, 
and it is expected to increase to more than 360,000,000 
patients by 2030.
1) Among patients with coronary 
artery diseases (CAD), the prevalence of DM has been 
reported to be even higher, and, conversely, the preval-
ence of cardiovascular diseases (CVD) is relatively higher 
in patients with DM.
2)3) In the Cardiovascular Health 
Study, which is a population based study in adults aged 
65 years or older, Barziay et al.
4) reported that the pre-
valence of clinical or subclinical CVD was 70% in those 
with normal glucose, 77% in those with an impaired fast-
ing glucose and 86% in those with a newly diagnosed 
or known DM. As blood glucose levels increase, the in-
cidence of clinical or preclinical atherosclerosis also in-
creases.
4) 
Insulin resistance (IR) has been proposed to be a risk 
factor for CVD, together with hyperglycemia, dyslipide-
mia, hypertension, etc.
5) IR can be measured with a ho-
meostasis model assessment-IR (HOMA-IR)
6) assay and 
insulin sensitivity can be measured with a quantitative 
insulin-sensitivity check index (QUICKI).
7) The Verona 
Diabetes Complication study, which was conducted in 
patients with type 2 DM, showed that HOMA-IR was 
correlated with the prevalence of CVD.
5) Some studies 
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suggested that IR can be defined as a HOMA-IR score 
of  ≥3.0-3.5 in Korean patients, and showed that as 
HOMA-IR was increased, risk factors for metabolic syn-
drome were also increased.
8-10) However, Adler et al.
11) 
reported that IR and insulin sensitivity were associated 
with risk factors of CVD including age, body mass index 
(BMI), triglycerides, cholesterol, and systolic blood pres-
sure, but not with DM, an independent predictor of 
CVD in patients. 
On the other hand, carotid intima-media thickness 
(CIMT) and vascular endothelial function, which have 
frequently been used as a surrogate marker of athero-
sclerosis, have also been reported to be independent risk 
factors for CVD. These surrogates are associated with 
risk factors of CVD including hypertension, smoking, 
DM and dyslipidemia.
12-15) 
Therefore, we sought to determine, in patients with 
coronary atherosclerosis, the prevalence of impaired 
glucose tolerance (IGT) and DM, and IR and insulin 
sensitivity. The second purpose of this study was to as-
sess the relationship between (a) CIMT and (b) endo-
thelial function, IR and insulin sensitivity in this study 
population. 
 
Subjects and Methods 
 
Subjects 
Study subjects consisted of 187 consecutive patients 
who underwent coronary angiography (CAG) at Kon-
yang University Hospital from September 2003 to May 
2004.  
CAD was defined by stenosis  ≥50% of the diame-
ter of the lumen of a major epicardial coronary artery 
(left anterior descending artery, left circumflex artery 
or right coronary artery). Based on this definition, 88 
patients (47.9%) had CAD and 99 patients (52.9%) had 
mild stenosis (<50%) (Table 1). Coronary risk factors 
including hypertension and smoking and clinical para-
meters including blood pressure, height and body weight 
were evaluated in all patients. We also measured cho-
lesterol, triglyceride, low-density lipoprotein-choleste-
rol (LDL-C), high-density lipoprotein-cholesterol (HDL-
C), high sensitivity C-reactive protein (hs-CRP), uric 
acid and homocysteine. 
 
Oral glucose tolerance test, insulin resistance and 
insulin sensitivity   
For the oral glucose tolerance test (OGTT), fasting pla-
sma glucose, insulin and the concentration of C-pep-
tide were measured after the patient had been at least 
8 hours in a fasting state. Plasma glucose level was meas-
ured again at 60 and 120 minutes after intake of 75 g 
of glucose. Based on the results of the OGTT, new DM 
was defined as a fasting blood sugar (FBS) level  ≥126 
mg/dL or a plasma glucose level (120 minutes)  ≥200 
mg/dL. IGT was defined at 120 minutes as a plasma 
glucose level >140 mg/dL but <200 mg/dL. Patients 
who were receiving treatment for underlying DM were 
defined as “known DM”. 
Calculation of IR was done based on the concen-
trations of FBS and insulin. HOMA-IR was calculated 
based on the formula reported by Matthews et al.
6) as 
shown below: 
HOMA-IR={Fasting serum insulin value (in mU/L)× 
Table 1. Clinical characteristics of patients 
Variables  Values 
Number (n)  187 
Age (years)  61±9.6
Male sex, n (%)  094 (63.9)
Medication (n)   
Aspirin   48 
Clopidogrel 20 
β-blocker 20 
ACE inhibitor  07 
Statin 13 
Stable angina, n (%)  166 (88.8)
Acute coronary syndrome, n (%)  021 (11.2)
CAD, n (%)   
Minimal  099 (52.9)
1 vessel disease  045 (24.1)
2 vessels disease  028 (15).0
3 vessels disease  015 (8).00
Treatment, n (%)   
Medication 120  (64.2)
PCI  067 (35.8)
BMI (kg/m
2) 24.5±3.0
Hypertension, n (%)  086 (46).0
Dyslipidemia, n (%)  055 (29.4)
Diabetes, n (%)  106 (56.7)
Tobacco use, n (%)  048 (25.7)
Old MI, n (%)  035 (18.7)
LV ejection fraction (%)  64.7±10.3
Total cholesterol (mg/dL)  176.3±42
Triglyceride (mg/dL)  155.5±83
LDL-C (mg/dL)  108±34
HDL-C (mg/dL)  40.1±9.9
Fasting blood glucose (mg/dL)  117.1±39.6
Homocysteine (mg/dL)  10.3±4.2
hs-CRP (mg/dL)  0.284±0.32
Uric acid (mg/dL)  5.0±1.6
Carotid IMT (mm)  0.91±0.2
FMD (%)  4.8±2.0
ACE: angiotensin converting enzyme, CAD: coronary artery disease, 
PCI: percutaneous coronary intervention, BMI: body mass index, 
MI: myocardial infarction, LV: left ventricular, LDL-C: low-density 
lipoprotein-cholesterol, HDL-C: high-density lipoprotein-choleste-
rol, hs-CRP: high sensitivity C-reactive protein, IMT: intima-me-
dia thickness, FMD: flow-mediated dilatation 
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Fasting plasma glucose (in mg/dL)}/405 
For the measurement of insulin sensitivity, the QUI-
CKI index was calculated based on the methods report-
ed by Katz et al.
7) as shown below: 
QUICKI=1/[{log(fasting insulin in mU/l)+log (fast-
ing plasma glucose in mg/dL)}] 
In the current study, IR was defined as a HOMA-IR sc-
ore  ≥3.0 based on previous studies of Korean patients.
8-10) 
 
Coronary angiography 
CAG was performed using a standard technique th-
rough the right femoral or radial artery. CAG was ana-
lyzed using online-quantitative coronary angiographic 
analysis (Philips, Integris c5000, Amsterdam, Nether-
land). Significant stenosis was defined as ≥50% dia-
meter stenosis. 
 
Measurement of endothelial function and carotid 
intima-media thickness 
Flow-mediated brachial artery dilatation (FMD) was 
measured using high-resolution ultrasound (Hewlett-
Packard Sonos 5500, Palo Alto, CA, USA) with an 11-
3L (3-11 MHz) probe for evaluation of endothelial func-
tion. FMD was measured using methods that were pro-
posed by Celermajer et al.
16) in 1992. At first, the bra-
chial artery was defined by the optimal gain control of 
the high resolutionultrasound three to five centimeters 
above the elbow. Then, the media to media distance of 
the brachial artery was measured at end diastole and 
the time velocity integral was obtained in the center of 
the brachial artery by Doppler ultrasound. The site at 
which the probe was positioned was marked and the 
landmark of the ultrasound image including branch and 
plaque was used for measurement of the same brachial 
artery site during the hyperemic phase. After measur-
ing the brachial artery diameter and time velocity in-
tegral, the cuff of the sphygmomanometer was inflated 
up to 60 mmHg after the flow of the brachial artery had 
disappeared from the forearm for 5 minutes. Hyperemic 
blood flow was induced after decompression of the 
blood pressure cuff. The media-to-media distance and 
the time velocity integral at the same brachial artery 
site was measured 1 minute after decompression of cuff. 
The FMD was expressed as % change in the diameter 
of the hyperemic brachial artery relative to the baseline 
brachial artery diameter. 
CIMT was also measured using high-resolution ul-
trasonography with the same product specifications, dur-
ing which patients were placed in the supine position 
with their head extended into a dark room where the 
temperature and humidity were adjusted and the left 
common carotid artery was measured. The CIMT was 
measured in a 10 mm long segment just proximal to 
the carotid bulb in the common carotid artery and de-
fined as the distance from the leading edge of the lu-
men-intima interface to the leading edge of the media-
adventitia interface of the far wall. M’ATH
® software 
(version 2.01, METRIS Co., Argenteuil, France) was 
used to determine accuracy and repeatability. M’ATH
® 
software measures CIMT using a semi-automatic me-
thod. This digitalized measurement method has been 
reported to be greater than 4 fold more accurate than 
the conventional type of passive-mode measurement.
17) 
To obtain optimal images, the depth and gain of ultra-
sonography were controlled. Depth control of the ultra-
sonography was fixed in a consistent manner for the 
purpose of calibration. An ultrasonographic gain was 
controlled to obtain images indicating the optimal in-
tima, media and adventitia during the test. After opti-
mal images were obtained, the imaging data were stored 
in a computer in which M’ATH
® software was install-
ed. M’ATH
® software automatically calculates the mean 
for IMT. Testers selected the areas where the images 
were clearly visible at a 1 cm proximal location from the 
carotid bulb or they selected the interval whose length 
was approximately 1 cm with a quality index ≥0.60 
to measured the IMT using M’ATH
® software. 
 
Statistical analysis 
A comparison of data was made using the Statistical 
Package for the Social Sciences (SPSS) statistics program 
(version 12.0, USA). Then, the characteristics of patients 
were expressed as mean±SD. An analysis of the effects 
of each risk factor on atherosclerosis indicators was done 
using Pearson correlation analysis. Correlations between 
the tertiles of HOMA-IR/QUICKI and CIMT and en-
dothelium-dependent vasodilatory responses were analyz-
ed using ANOVA. A p of <0.05 was considered statis-
tically significant. 
 
Results 
 
Clinical characteristics 
Study subjects consisted of 187 patients {mean: 61.3
±9.6 year-old, male gender 50.3% (n=94)} (Table 1). 
The prevalence of hypertension, DM, dyslipidemia and 
smoking was, respectively, 46% (n=86), 56.7% (n= 
106), 29.4% (n=55) and 25.7% (n=48). CAG showed 
that 88 patients (47.1%) had significant CAD. In these 
patients, the prevalence of single vessel disease was 
24.1% (n=45), two vessel disease 15% (n=28) and three 
vessel disease 8% (n=15). The reason that CAG was 
done included stable angina in 166 patients (88.8%) 
and acute coronary syndrome (ACS) in 21 patients 
(11.2%). Mean BMI was 24.5±3.0 kg/m
2 and left ven-
tricular ejection fraction measured by transthoracic echo-
cardiography was 64.7±10.3%. Laboratory tests show-
ed a total cholesterol of 176.3±42.0 mg/dL, a trigly-
ceride level of 155.5±83.2 mg/dL, an LDL-C of 108.0 
±34.1 mg/dL, an HDL-C of 40.1±9.9 mg/dL, an FBS  
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of 117.1±39.6 mg/dL, homocysteine levels of 10.3±
4.2 mg/dL, hs-CRP of 0.284±0.32 mg/dL and a uric 
acid of 5.0±1.6 mg/dL. Mean CIMT was 0.9±0.2 mm 
and mean FMD was 4.8±2.0%. 
 
The prevalence of diabetes mellitus   
Among all patients, DM was already known in 33.7% 
(n=63), new DM was found in 23% (n=43) and IGT 
was found in 31% (n=58). Of patients who already 
had DM, 16 were receiving insulin therapy and 47 were 
receiving oral anti-hyperglycemic agents. FBS and fast-
ing insulin levels were 93.2±8.2 mg/dL and 8.9±2.1 
IU/L, respectively, in non-DM patients, were 101.3±
11.3 mg/dL and 10.2±4.1 IU/L in IGT patients, were 
123.3±47.4 mg/dL and 11.1±7.3 IU/L in new DM 
patients, and were 138.2±40.1 mg/dL and 10.3±5.4 
IU/L in known DM patients. The prevalence of DM did 
not have any difference between stable angina group and 
ACS group (46.3% vs. 46.1%) (p=ns). The prevalence 
of DM was 43.5% (n=22) in patients with single ves-
sel disease, 58.2% (n=25) in patients with multi-vessel 
disease and 43.5% (n=42) in patients without signifi-
cant stenosis. The prevalence of DM was increased in 
patients with multi-vessel disease, but this change was 
not statistically significant. 
Correlations between insulin resistance, insulin sen-
sitivity and indicators of atherosclerosis 
Mean HOMA-IR was 2.97±1.8 and mean QUIC-
KI was 0.58±0.1. Using the definition of IR being 
HOMA-IR  ≥3.0, there were 71 patients (38%) who had 
IR. The prevalence of IR was 21% (n=5) in non-DM 
patients, 34% (n=20) in patients with IGT, 44% (n= 
19) in patients with new DM and 42% (n=27) in pa-
tients with known DM (Table 2). The prevalence of IR 
was 35% (n=16) in patients with single vessel disease, 
43% (n=18) in patients with multi-vessel disease and 
was 37% (n=37) in patients without significant steno-
sis. The prevalence of IR was increased in patients with 
multi-vessel disease, but this change was not statistically 
significant. There were significant positive correlations 
between HOMA-IR and BMI (r=0.28, p=0.0001) and 
HOMA-IR and triglyceride (r=0.2, p=0.01). But there 
were no correlations between HOMA-IR and FMD (r= 
-0.23, p=0.41) or CIMT (r=0.10, p=0.23). There were 
significant negative correlations between QUICKI and 
BMI (r=-0.26, p=0.0004), total cholesterol (r=-0.15, 
p=0.04), triglycerides (r=-0.21, p=0.004) and LDL-C 
(r=-0.17, p=0.02). But there were no correlations bet-
ween QUCKI and FMD (r=-0.07, p=0.41) or CIMT 
(r=-0.13, p=0.13) (Table 3). Study subjects were divided 
into three groups according to HOMA-IR and QUICKI. 
CIMT and endothelium-dependent vasodilatory res-
ponses did not show any differences between groups 
(Table 4).  
 
Correlations between Endothelium-Dependent Va-
sodilatation, intima-media thickness and risk factors 
Among all patients, an analysis of the correlations 
between endothelium-dependent vasodilatation, CIMT 
Table 3. Comparison of Pearson correlation coefficients between insulin resistance, atherosclerosis surrogate and each coronary artery 
disease risk factors 
       FMD     CIMT  HOMA-IR     QUICKI 
    r  p  r  p  r  p  r  p 
FMD     -0.1400 0.100  -0.07 0.4100  -0.10 0.41 
IMT  -0.14 0.10     -0.10 0.2300  -0.10 0.13 
HOMA-IR  -0.07 0.41 -0.1000 0.230     -0.80 0.001
QUICKI  -0.10 0.41 -0.1300 0.130  -0.80 0.0010    
Age  -0.20 0.02 -0.1500 0.009 -0.10 0.1400  -0.13 0.08 
BMI  -0.10 0.50  -0.1300 0.140  -0.28 0.0001 -0.26 0.0004
TC  -0.12 0.16 -0.1900 0.020  -0.13 0.0700  -0.15 0.04 
TG  -0.04 0.61 -0.0200 0.830  -0.20 0.0100  -0.21 0.004
HDL-C  -0.10 0.50  -0.1400 0.110  -0.01 0.8500  -0.02 0.84 
LDL-C  -0.16 0.06 -0.2600 0.002  -0.14 0.0600  -0.17 0.02 
hs-CRP  -0.10 0.30  -0.0300 0.770  -0.02 0.7500  -0.10 0.18 
Homocysteine  -0.20 0.01 -0.0010 0.990  -0.07 0.3700  -0.08 0.26 
Uric acid  -0.20 0.05 -0.0001 0.970  -0.08 0.2900  -0.06 0.41 
FMD: flow mediated dilatation, CIMT: carotid intima-media thickness, HOMA-IR: model assessment insulin resistance, QUICKI: quan-
titative insulin sensitivity check index, BMI: body mass index, TC: total cholesterol, TG: triglyceride, HDL-C: high-density lipoprotein-cho-
lesterol, LDL-C: low-density lipoprotein-cholesterol, hsCRP: high sensitivity C-reactive protein reactive protein 
 
Table 2. Prevalence of insulin resistance and mean HOMA-IR 
by glucose status 
  IR, n (%)  Median & IQR
Normal  05 (21)  1.80, 1.18 
Insulin glucose tolerance  20 (34)  2.20, 1.41 
New DM  19 (44)  2.96, 2.98 
Known DM  27 (42)  3.02, 2.21 
HOMA-IR: homeostasis model assessment-insulin resistance, IR:
insulin resistance, IQR: interquartile range, DM: diabetes mellitus
  
 
66·Atherosclerosis Surrogates in DM or IGT 
 
and cardiovascular risk factors were done. CIMT was 
correlated with total cholesterol (r=0.19, p=0.02) and 
LDL-C  (r=0.26, p=0.002). Endothelium-dependent 
vasodilatation was correlated with age (r=-0.19, p= 
0.02) and homocysteine level (r=-0.23, p=0.01). How-
ever, CIMT and endothelium-dependent vasodilata-
tion did not correlate with HDL-C, triglyceride, uric acid 
or FBS (Table 3). 
 
Discussion 
 
It has been reported that the worldwide prevalence 
of DM is rising. In Korea, according to reports by Kim 
et al.
18) in 2005, the prevalence of DM was 2.26% in 
adult males and 2.03% in females and was persistently 
increasing.  
Major outcomes of the current study are that the pre-
valence of known DM (33.7%, n=63), new DM (22%, 
n=43) and IGT (31%, n=58) are high in patients with 
coronary atherosclerosis. According to other studies which 
were done in CAD patients, however, the prevalence of 
DM at the time of admission was 27%.
19) In the current 
study, the prevalence of DM was 55.7% (known DM 
33.7% and new DM 22%). A single measurement of 
FBS in patient with ACS may have contributed to the 
high prevalence of DM in our study. And, the preval-
ence of DM can vary depending on study subjects. Th-
erefore, our study does not represent the true preval-
ence of DM in Korean patients with CAD. However, 
OGTT was done for all subjects to evaluate DM and IGT, 
and DM was newly diagnosed in many patients. Ac-
cordingly, more efforts are needed to evaluate DM in 
patients with coronary atherosclerosis. The prevalence 
of DM and IR can vary according to the number of af-
fected blood vessels. In the current study, however, the 
prevalence of DM and IR was increased, but the incre-
ases were not statistically significant. The number of 
enrolled patients was relatively small. As mentioned ear-
lier, the prevalence of DM and IR were assumed to in-
crease due to the effects of other extrinsic factors. 
In a study of Koreans, IR was defined as HOMA-IR 
≥3.0-3.5.
8-10) Also in the current study, cases of HO-
MA-IR  ≥3.0 were defined as IR. In patients with co-
ronary atherosclerosis, which included both those with 
DM and non-diabetic patients, the number of patients 
with IR was 71 (38%), and this corresponded to a rela-
tively greater figure. 
Ohnishi et al.
20) reported that IR correlated with cor-
onary risk factors including blood pressure, BMI, tri-
glycerides and LDL-C. In the current study, IR meas-
ured by HOMA-IR positively correlated with BMI and 
triglycerides and insulin sensitivity and QUICKI scores 
negatively correlated with BMI, total cholesterol and 
LDL-C. CIMT and endothelium-dependent vasodilat-
ation are used as surrogate marker of atherosclerosis and 
associated with coronary risk factors. CIMT was asso-
ciated with age, sex, cholesterol, LDL-C and pulse pres-
sure.
21) Endothelium-dependent vasodilatation was as-
sociated with age, sex and the number of risk factors of 
atherosclerosis.
22) Also in the current study, these indi-
cators were associated with coronary risk factors. But 
there were no significant correlations between IR, in-
sulin sensitivity, endothelium-dependent vasodilatat-
ion and CIMT. According to the report by Giannini et 
al.
23) in obese children at the prepubertal period, as 
HOMA-IR was increased CIMT was also increased. Ma-
kino et al.
24) reported that there was a significant cor-
relation between endothelium-dependent vasodilata-
tion and IR in patients with DM. The current study was 
conducted in patients who had coronary atheroscle-
rosis, which showed that CIMT was 0.91±0.2 mm on 
average. According to the report by Bae et al.
 21) mean 
CIMT was 0.63±0.11 mm in Korean people. In the cur-
rent study, however, CIMT was increased, and this may 
explain the discrepancy from other studies. 
The current study has some limitations. This is not 
a case controlled study and the number of study sub-
jects was relatively small. Also, we mostly studied cases 
of advanced coronary atherosclerosis. There were no cli-
nical follow-up data for patients who were newly diag-
nosed with DM or IGT. Further studies are now need-
ed to evaluate the prognostic value of active diagnosis 
of in patients with coronary atherosclerosis. 
In conclusion, this study showed that the prevalence 
of new DM and IGT is relatively higher in older pa-
tients with coronary atherosclerosis than in older indi-
viduals in the general population. Accordingly, in pa-
tients with coronary atherosclerosis, active diagnosis and 
treatment for DM is mandatory to improve patient prog-
nosis. There were no significant correlations between 
IR, insulin sensitivity, CIMT and endothelium-depend-
ent vasodilatation. But these indicators show changes 
that represent the early stage of atherosclerosis. Further 
studies are now warranted to examine the above cor-
relations in patients without coronary atherosclerosis.
 
Table 4. Endothelial function and carotid intima-media thick-
ness according to tertiles of HOMA-IR/QUICKI 
  FMD  CIMT 
HOMA-IR    
Low 4.66±1.79 (n=46) 0.89±0.16 (n=44)
Middle 5.10±2.07 (n=50) 0.95±0.27 (n=43)
High 4.70±2.27 (n=51) 0.92±0.18 (n=46)
QUICKI    
Low 4.67±2.31 (n=46) 0.92±0.19 (n=42)
Middle 5.13±2.05 (n=54) 0.94±0.27 (n=46)
High 4.16±1.79 (n=46) 0.89±0.16 (n=44)
There were no significant differences among any tertiles of HOMA-
IR/QUICKI. FMD: flow mediated dilatation, CIMT: carotid in-
tima-media thickness, HOMA-IR: model assessment insulin resist-
ance, QUICKI: quantitative insulin sensitivity check index 
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